8-Hydroxy Quinaldine

8-Hydroxy Quinaldine

SCHEMBL4304584

Cc1ccc2cccc(O)c2n1.Cc1ccc2cccc(O)c2n1.[BeH2]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 2/20 0.96
PLAU P00749 1/20 0.57
NCF1 P14598 1/20 0.57
RAB9A P51151 4/20 0.56
CCR1 P32246 1/20 0.56
CCR5 P51681 1/20 0.56
ALDH1A1 P00352 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2C9 P11712 1/20 0.55
HPGD P15428 1/20 0.55
ALOX12 P18054 1/20 0.55
CYP2C19 P33261 1/20 0.55
HIF1A Q16665 1/20 0.55
HSD17B10 Q99714 1/20 0.55
PARP1 P09874 1/20 0.53
KMT2A Q03164 7/20 0.52
KDM4E B2RXH2 5/20 0.52
SOS2 Q07890 1/20 0.52
MEN1 O00255 5/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
8-Hydroxy Quinaldine SCHEMBL297247 0.98 METAP2 (1.00) METAP2PLAUNCF1RAB9ACCR1
8-Hydroxy Quinaldine SCHEMBL29483489 0.98 METAP2 (1.00) METAP2PLAUNCF1RAB9ACCR1
8-Hydroxy Quinaldine SCHEMBL4762935 0.96 METAP2 (0.96) METAP2PLAUNCF1RAB9ACCR1
8-Hydroxy Quinaldine SCHEMBL7179747 0.96 METAP2 (0.96) METAP2PLAUNCF1RAB9ACCR1
8-Hydroxy Quinaldine SCHEMBL546577 0.96 METAP2 (0.96) METAP2PLAUNCF1RAB9ACCR1
8-Hydroxy Quinaldine SCHEMBL9154369 0.96 METAP2 (0.96) METAP2PLAUNCF1RAB9ACCR1
8-Hydroxy Quinaldine SCHEMBL9154936 0.96 METAP2 (0.96) METAP2PLAUNCF1RAB9ACCR1
8-Hydroxy Quinaldine SCHEMBL5089361 0.96 METAP2 (0.96) METAP2PLAUNCF1RAB9ACCR1
8-Hydroxy Quinaldine SCHEMBL22734876 0.96 METAP2 (0.96) METAP2PLAUNCF1RAB9ACCR1
8-Hydroxy Quinaldine SCHEMBL4286984 0.96 METAP2 (0.96) METAP2PLAUNCF1RAB9ACCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5516577-A Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 1996-05-14 US claimed
EP-0569827-A2 Organic electroluminescence device IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-11-18 EP claimed
US-7514158-B2 Coumarin compound KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2009-04-07 US disclosed
US-20070248769-A1 Cover film for organic electroluminescence devices, organic electroluminescence device using the cover film and process for producing the device TIS INTERNATIONAL, INC. 2007-10-25 US disclosed
US-20070018568-A1 Organic electroluminescent device KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) 2007-01-25 US disclosed
US-20060228577-A1 Organic electroluminescent device KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) 2006-10-12 US disclosed
US-7008883-B2 Photoresist composition for forming an insulation film, insulation film for organic electroluminescence devices and process for producing the insulation film ZEON CORPORATION (JP) 2006-03-07 US disclosed
US-20050275341-A1 Coumarin compound KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2005-12-15 US disclosed
EP-1599074-A1 ORGANIC ELECTROLUMINESCENT DEVICE Kabushiki Kaisha Toyota Jidoshokki (JP) 2005-11-23 EP disclosed
EP-1560469-A1 ORGANIC ELECTROLUMINESCENT DEVICE Kabushiki Kaisha Toyota Jidoshokki (JP) 2005-08-03 EP disclosed
US-20050019585-A1 comprises polymers of decomposition products of a perfluoroolefin (Perfluorocyclopentene); good transparency ZEON CORPORATION (JP) 2005-01-27 US disclosed
EP-1473974-A1 COVER FILM FOR ORGANIC ELECTROLUMINESCENCE DEVICE, ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING SAME, AND ITS MANUFACTURING METHOD ZEON CORPORATION (JP) 2004-11-03 EP disclosed
US-20040096771-A1 Photoresist composition for forming an insulation film, insulation film for organic electroluminescence element and method for itis formation ZEON CORPORATION (JP) 2004-05-20 US disclosed
EP-1144543-B1 ELECTROLUMINESCENT QUINOLATES SOUTH BANK UNIV ENTPR LTD (GB) 2004-03-17 EP disclosed
EP-1321821-A1 PHOTORESIST COMPOSITION FOR FORMING INSULATION FILM, INSULATION FILM FOR ORGANIC ELECTROLUMINESCENCE ELEMENT AND METHOD FOR ITS FORMATION NIPPON ZEON CO., LTD. (JP) 2003-06-25 EP disclosed
EP-0781075-B1 METHOD FOR SEALING ORGANIC EL ELEMENT AND ORGANIC EL ELEMENT IDEMITSU KOSAN CO (JP) 2001-12-05 EP disclosed
US-5962962-A Method of encapsulating organic electroluminescence device and organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 1999-10-05 US disclosed
EP-0781075-A1 METHOD FOR SEALING ORGANIC EL ELEMENT AND ORGANIC EL ELEMENT IDEMITSU KOSAN COMPANY LIMITED (JP) 1997-06-25 EP disclosed
US-5516577-A Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 1996-05-14 US disclosed
EP-0569827-A2 Organic electroluminescence device IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-11-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050275341-A1 Coumarin compound XPO1, VKORC1, XPO5 METAP2 2661/4885PLAU 1222/4885NCF1 1366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.